Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis

Journal of Hepatology

Volumn 46, Issue 5, 2007, Pages 899-906

  Karlsen, Tom H ^a   Boberg, Kirsten Muri ^a   Olsson, Marita ^b   Sun, Ji Yao ^c   Senitzer, David ^c   Bergquist, Annika ^d   Schrumpf, Erik ^a   Thorsby, Erik ^a   Lie, Benedicte A ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Genetic susceptibility; Human leukocyte antigen; Killer immunoglobulin like receptor; Natural killer cells; Primary sclerosing cholangitis

Indexed keywords

HLA ANTIGEN CLASS 1; HLA DR ANTIGEN; LIGAND; NATURAL KILLER CELL RECEPTOR;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NATURAL KILLER CELL; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SCANDINAVIA; SCHOOL CHILD; STATISTICAL SIGNIFICANCE;

EID: 34047187448     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.01.032     Document Type: Article

References (46)

1. Chapman R.W., Arborgh B.A., Rhodes J.M., Summerfield J.A., Dick R., Scheuer P.J., et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 21 (1980) 870-877
2. Saarinen S., Olerup O., and Broome U. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol 95 (2000) 3195-3199
3. Bergquist A., Lindberg G., Saarinen S., and Broome U. Increased prevalence of primary sclerosing cholangitis among first-degree relatives. J Hepatol 42 (2005) 252-256
4. Donaldson P.T., and Norris S. Immunogenetics in PSC. Best Pract Res Clin Gastroenterol 15 (2001) 611-627
5. Schrumpf E., Fausa O., Forre O., Dobloug J.H., Ritland S., and Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 17 (1982) 187-191
6. Chapman R.W., Varghese Z., Gaul R., Patel G., Kokinon N., and Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut 24 (1983) 38-41
7. Moloney M.M., Thomson L.J., Strettell M.J., Williams R., and Donaldson P.T. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis. Hepatology 28 (1998) 660-662
8. Wiencke K., Spurkland A., Schrumpf E., and Boberg K.M. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology 34 (2001) 625-630
9. Norris S., Kondeatis E., Collins R., Satsangi J., Clare M., Chapman R., et al. Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism. Gastroenterology 120 (2001) 1475-1482
10. Gaudieri S., Kulski J.K., Dawkins R.L., and Gojobori T. Different evolutionary histories in two subgenomic regions of the major histocompatibility complex. Genome Res 9 (1999) 541-549
11. Orange J.S., and Ballas Z.K. Natural killer cells in human health and disease. Clin Immunol 118 (2006) 1-10
12. Hayday A., and Tigelaar R. Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 3 (2003) 233-242
13. Donaldson P.T., and Norris S. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity 35 (2002) 555-564
14. Hamerman J.A., Ogasawara K., and Lanier L.L. NK cells in innate immunity. Curr Opin Immunol 17 (2005) 29-35
15. Hashimoto E., Lindor K.D., Homburger H.A., Dickson E.R., Czaja A.J., Wiesner R.H., et al. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc 68 (1993) 1049-1055
16. Hata K., Van Thiel D.H., Herberman R.B., and Whiteside T.L. Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease. Hepatology 15 (1992) 816-823
17. Silvain C., Zeevi A., Saidman S., Duquesnoy R.J., and Van Thiel D.H. Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease. Hepatogastroenterology 42 (1995) 250-258
18. Hsu K.C., Chida S., Geraghty D.E., and Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 190 (2002) 40-52
19. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5 (2005) 201-214
20. van Bergen J., Thompson A., van der Slik A., Ottenhoff T.H., Gussekloo J., and Koning F. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol 173 (2004) 6719-6726
21. Rajagopalan S., and Long E.O. Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 201 (2005) 1025-1029
22. Khakoo S.I., Thio C.L., Martin M.P., Brooks C.R., Gao X., Astemborski J., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305 (2004) 872-874
23. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31 (2002) 429-434
24. Nelson G.W., Martin M.P., Gladman D., Wade J., Trowsdale J., and Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 173 (2004) 4273-4276
25. Jones D.C., Edgar R.S., Ahmad T., Cummings J.R., Jewell D.P., Trowsdale J., et al. Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility. Genes Immun 7 (2006) 576-582
26. Barker D.L., Hansen M.S., Faruqi A.F., Giannola D., Irsula O.R., Lasken R.S., et al. Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel. Genome Res 14 (2004) 901-907
27. Sayer D.C., Whidborne R., De Santis D., Rozemuller E.H., Christiansen F.T., and Tilanus M.G. A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3,4,5. Tissue Antigens 63 (2004) 412-423
28. Winter C.C., Gumperz J.E., Parham P., Long E.O., and Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 161 (1998) 571-577
29. Muller C.A., Engler-Blum G., Gekeler V., Steiert I., Weiss E., and Schmidt H. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6. Immunogenetics 30 (1989) 200-207
30. Sun J.Y., Gaidulis L., Miller M.M., Goto R.M., Rodriguez R., Forman S.J., et al. Development of a multiplex PCR-SSP method for Killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens 64 (2004) 462-468
31. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
32. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25 (2003) 115-121
33. Westfall P.H., Zaykin D.V., and Young S.S. Multiple tests for genetic effects in association studies. In: Looney S.W. (Ed). Biostatistical methods (2002), Humana Press Inc., New Jersey 143-168
34. Spurkland A., Saarinen S., Boberg K.M., Mitchell S., Broome U., Caballeria L., et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53 (1999) 459-469
35. Pazmany L. Do NK cells regulate human autoimmunity?. Cytokine 32 (2005) 76-80
36. Raulet D.H., and Vance R.E. Self-tolerance of natural killer cells. Nat Rev Immunol 6 (2006) 520-531
37. Cerwenka A., and Lanier L.L. Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev 181 (2001) 158-169
38. Suemizu H., Radosavljevic M., Kimura M., Sadahiro S., Yoshimura S., Bahram S., et al. A basolateral sorting motif in the MICA cytoplasmic tail. Proc Natl Acad Sci U S A 99 (2002) 2971-2976
39. Stastny P. Introduction: MICA/MICB in innate immunity, adaptive immunity, autoimmunity, cancer, and in the immune response to transplants. Hum Immunol 67 (2006) 141-144
40. Shi F.D., and Van Kaer L. Reciprocal regulation between natural killer cells and autoreactive T cells. Nat Rev Immunol 6 (2006) 751-760
41. Corthay A. A three-cell model for activation of naive T helper cells. Scand J Immunol 64 (2006) 93-96
42. Anfossi N., Robbins S.H., Ugolini S., Georgel P., Hoebe K., Bouneaud C., et al. Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules. J Immunol 173 (2004) 3773-3782
43. Kapp J.A., Kapp L.M., and McKenna K.C. Gammadelta T cells play an essential role in several forms of tolerance. Immunol Res 29 (2004) 93-102
44. Martins E.B., Graham A.K., Chapman R.W., and Fleming K.A. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology 23 (1996) 988-993
45. Ponsioen C.Y., Kuiper H., Ten Kate F.J., van Milligen de Wit M., van Deventer S.J., and Tytgat G.N. Immunohistochemical analysis of inflammation in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 11 (1999) 769-774
46. Carr W.H., Pando M.J., and Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol 175 (2005) 5222-5229